Europe Genetic Testing Market - Industry Analysis and Market Forecast 2017 - 2022

  • ID: 4387085
  • Report
  • Region: Europe
  • 120 pages
  • Mordor Intelligence
1 of 3
The European genetic testing market accounted for USD 1.13 million in 2015 and is estimated to reach USD 1.22 billion in 2016. The market value is expected to reach USD 1.81 billion by 2021, growing at a CAGR of 8.2% during the forecast period.

Genetic testing has become quite prevalent in Europe over the last few years, with recent developments in molecular medicine expected to provide further impetus to this critical area. The integration of these technologies into the healthcare system necessitates that their application is implemented within a responsible framework of accompanying measures and activities.

As a consequence, genetic testing has been subjected to policy debates at various institutional and international levels. The European Commission has recognized certain salient topics involving genetic testing that need further clarity, including regional distribution of genetic services, suggestions for the rationalization of services, methods for improving national accreditation of genetic laboratories, long-term organization of external quality assessment, validation of next generation sequencing platforms and applications, and perspectives on direct-to-consumer genetic testing.

The report segments the market by type and geography. By type, the market is segmented into the carrier, diagnostic, newborn, predictive and presymptomatic, and prenatal testing. By geography, the market is segmented into Germany, France, Italy, the UK and the rest of Europe.

While Germany accounts for the largest share of the genetic testing market in Europe, the demand for these tests is likely to be the fastest growing in the United Kingdom during 2016-2021.

Some of the key players in Europegenetic testing market are:

Key Deliverables:

Market analysis for Europegenetic testing market, with region-specific assessments and competition analysis on the global and regional scale.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect Europegenetic testing market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions where this industry is blooming and to also identify the regions that are still untapped.

In-depth analysis of the geographical and market factors that affect the growth of Europegenetic testing market.

Strategic assessment of indicators, market impact analysis, regional variation, current/ future market trends and profiles of major/niche global market participants.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 INTRODUCTION
1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY
2 EUROPE GENETIC TESTING MARKET FORCES
2.1 MARKET DRIVERS
2.2 MARKET RESTRAINTS
2.3 OPPORTUNITIES
3 EUROPE GENETIC TESTING MARKET, BY TYPES
3.1 OVERVIEW
3.1.1 Europe Genetic Testing Market, By Types, 2014-2020
3.2 CARRIER TESTING
3.3 DIAGNOSTIC TESTING
3.4 NEWBORN SCREENING
3.5 PREDICTIVE AND PRESYMPTOMATIC TESTING
3.6 PRENATAL TESTING
4 EUROPE GENETIC TESTING MARKET, BY GEOGRAPHY
4.1 OVERVIEW
4.1.1 Europe Genetic Testing Market, by Geography, 2014-2020
4.2 Germany
4.3 France
4.4 Italy
4.5 Spain
4.6 The United Kingdom
4.7 Rest of Europe
5. COMPETITIVE LANDSCAPE
6. COMPANY PROFILES
6.1 BIOCARTIS SA
6.1.1 Overview
6.1.2 Major Products and Services
6.1.3 Genetic Testing Pipeline Products
6.1.4 Financials
6.1.5 Developments
6.2 ARIOSA DIAGNOSTICS, Inc.
6.2.1 Overview
6.2.2 Major Products and Services
6.2.3 Genetic Testing Pipeline Products
6.3 BIOHELIX CORPORATION (Wholly Owned Subsidiary of Quidel)
6.3.1 Overview
6.3.2 Major Products and Services
6.3.3 Genetic Testing Pipeline Products
6.3.4 Financials
6.3.5 Developments
6.4 BIOMERIEUX S.A.
6.4.1 Overview
6.4.2 Major Products and Services
6.4.3 Genetic Testing Pipeline Products
6.4.4 Financials
6.4.5 Developments
6.5 EKF DIAGNOSTIC HOLDINGS PLC
6.5.1 Overview
6.5.2 Major Products and Services
6.5.3 Genetic Testing Pipeline Products
6.5.4 Financials
6.5.5 Developments
6.6 ITEGRAGEN SA
6.6.1 Overview
6.6.2 Major Products and Services
6.6.3 Financials
6.6.4 Developments
6.7 OXFORD BIODYNAMICS LTD.
6.7.1 Overview
6.7.2 Genetic Testing Pipeline Products
6.7.3 Financials
6.7.4 Developments
7. APPENDIX
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll